Mesoblast (MESO) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
MESO slides 4.8% to $13.28, a 3-month low on 2.9x normal volume. Closed at $13.28, -4.80% vs the prior close of $13.95. Day range $12.94–$13.91, opened at $13.91.
MESO daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — MESO slides 4.8% to $13.28, a 3-month low on 2.9x normal volume
- Closed at $13.28, -4.80% vs the prior close of $13.95. Day range $12.94–$13.91, opened at $13.91.
- Volume was 615.69K shares, 2.9x its 50-day average of 213.81K — unusually heavy trading.
- Price is -15.0% vs its 50-day average ($15.63) and -15.4% vs its 200-day average ($15.69).
- 52-week range $12.94–$21.50; today's close sits at 4% of that range, 38.2% below the 52-week high.
Oct 15, 2026 — MESO rises 1.2% to $13.95
- Closed at $13.95, +1.16% vs the prior close of $13.79. Day range $13.50–$14.00, opened at $13.56.
- Volume was 237.30K shares, 1.1x its 50-day average of 209.63K.
- Price is -11.0% vs its 50-day average ($15.67) and -11.2% vs its 200-day average ($15.71).
- 52-week range $13.05–$21.50; today's close sits at 11% of that range, 35.1% below the 52-week high.
- SEC filings that day: 6-K.
Oct 14, 2026 — MESO dips 0.8% to $13.79, 3 down days in a row
- Closed at $13.79, -0.79% vs the prior close of $13.90. Day range $13.68–$13.95, opened at $13.75.
- Volume was 225.60K shares, 1.1x its 50-day average of 207.50K.
- Price is -12.1% vs its 50-day average ($15.69) and -12.4% vs its 200-day average ($15.74).
- 52-week range $13.05–$21.50; today's close sits at 9% of that range, 35.9% below the 52-week high.
- That makes 3 straight losses.
Oct 13, 2026 — MESO dips 2.6% to $13.90
- Closed at $13.90, -2.59% vs the prior close of $14.27. Day range $13.90–$14.26, opened at $14.26.
- Volume was 260.40K shares, 1.3x its 50-day average of 206.87K.
- Price is -11.5% vs its 50-day average ($15.71) and -11.8% vs its 200-day average ($15.77).
- 52-week range $13.05–$21.50; today's close sits at 10% of that range, 35.3% below the 52-week high.
- SEC filings that day: 6-K.
Oct 12, 2026 — MESO ends flat (-0.1%) to $14.27
- Closed at $14.27, -0.14% vs the prior close of $14.29. Day range $14.27–$14.47, opened at $14.47.
- Volume was 143.80K shares, 0.7x its 50-day average of 207.18K.
- Price is -9.3% vs its 50-day average ($15.73) and -9.7% vs its 200-day average ($15.80).
- 52-week range $13.05–$21.50; today's close sits at 14% of that range, 33.6% below the 52-week high.
Oct 9, 2026 — MESO jumps 3.9% to $14.29
- Closed at $14.29, +3.93% vs the prior close of $13.75. Day range $13.93–$14.38, opened at $13.93.
- Volume was 178.20K shares, 0.9x its 50-day average of 207.13K.
- Price is -9.1% vs its 50-day average ($15.72) and -9.7% vs its 200-day average ($15.82).
- 52-week range $13.05–$21.50; today's close sits at 15% of that range, 33.5% below the 52-week high.
Oct 8, 2026 — MESO dips 1.4% to $13.75
- Closed at $13.75, -1.36% vs the prior close of $13.94. Day range $13.41–$13.76, opened at $13.62.
- Volume was 239.00K shares, 1.2x its 50-day average of 207.38K.
- Price is -12.6% vs its 50-day average ($15.73) and -13.2% vs its 200-day average ($15.85).
- 52-week range $13.05–$21.50; today's close sits at 8% of that range, 36.0% below the 52-week high.
Oct 7, 2026 — MESO rises 2.4% to $13.94
- Closed at $13.94, +2.42% vs the prior close of $13.61. Day range $13.71–$14.10, opened at $13.71.
- Volume was 240.60K shares, 1.2x its 50-day average of 206.76K.
- Price is -11.4% vs its 50-day average ($15.74) and -12.2% vs its 200-day average ($15.87).
- 52-week range $13.05–$21.50; today's close sits at 11% of that range, 35.2% below the 52-week high.
Oct 6, 2026 — MESO slides 4.3% to $13.61, a 3-month low on 2.0x normal volume
- Closed at $13.61, -4.29% vs the prior close of $14.22. Day range $13.58–$13.90, opened at $13.90.
- Volume was 403.80K shares, 2.0x its 50-day average of 205.19K — unusually heavy trading.
- Price is -13.6% vs its 50-day average ($15.75) and -14.4% vs its 200-day average ($15.90).
- 52-week range $13.05–$21.50; today's close sits at 7% of that range, 36.7% below the 52-week high.
Oct 5, 2026 — MESO rises 1.0% to $14.22
- Closed at $14.22, +0.99% vs the prior close of $14.08. Day range $13.97–$14.30, opened at $14.09.
- Volume was 180.30K shares, 0.9x its 50-day average of 205.35K.
- Price is -9.8% vs its 50-day average ($15.77) and -10.7% vs its 200-day average ($15.92).
- 52-week range $13.05–$21.50; today's close sits at 14% of that range, 33.9% below the 52-week high.
Oct 2, 2026 — MESO dips 1.7% to $14.08, a 3-month low, 3 down days in a row
- Closed at $14.08, -1.68% vs the prior close of $14.32. Day range $14.01–$14.34, opened at $14.34.
- Volume was 265.20K shares, 1.3x its 50-day average of 202.12K.
- Price is -10.8% vs its 50-day average ($15.79) and -11.7% vs its 200-day average ($15.94).
- 52-week range $13.05–$21.50; today's close sits at 12% of that range, 34.5% below the 52-week high.
- That makes 3 straight losses.
MESO latest news & SEC filings
Every SEC filing by or about MESO in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 16, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Oct 15, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Oct 13, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Sep 24, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Aug 27, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Aug 27, 2026 · Form 20-F — Annual report from a foreign company (20-F)
Annual report from a foreign company (20-F)
Key figures from this report aren't in the SEC's structured data yet (usually appears within a day or two).
Aug 25, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Aug 24, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Aug 18, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Jul 30, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Jul 21, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Jul 15, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Jul 14, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Jul 10, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Jul 9, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Things to know before you trade MESO
- How much it moves: over the last 20 sessions the average daily move was 2.36% (largest 4.8%).
- Liquidity: about 257.59K shares (≈$3.42M) trade per day on average.
- 52-week position: $13.28 vs a range of $12.94–$21.50 (4% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 25 open-market buys, 0 sales; latest: Gregory George bought 2,324,072 shares on Apr 10, 2026.
- Latest filings: 6-K Oct 16, 2026; 6-K Oct 15, 2026; 6-K Oct 13, 2026.
- Listing: Nasdaq · industry: Biological Products, (No Diagnostic Substances).
MESO market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 13.91 | 13.91 | 12.94 | 13.28 | 615.69K |
| Oct 15, 2026 | 13.56 | 14.00 | 13.50 | 13.95 | 290.00K |
| Oct 14, 2026 | 13.75 | 13.95 | 13.68 | 13.79 | 225.60K |
| Oct 13, 2026 | 14.26 | 14.26 | 13.90 | 13.90 | 260.40K |
| Oct 12, 2026 | 14.47 | 14.47 | 14.27 | 14.27 | 143.80K |
| Oct 9, 2026 | 13.93 | 14.38 | 13.93 | 14.29 | 178.20K |
| Oct 8, 2026 | 13.62 | 13.76 | 13.41 | 13.75 | 239.00K |
| Oct 7, 2026 | 13.71 | 14.10 | 13.71 | 13.94 | 240.60K |
| Oct 6, 2026 | 13.90 | 13.90 | 13.58 | 13.61 | 403.80K |
| Oct 5, 2026 | 14.09 | 14.30 | 13.97 | 14.22 | 180.30K |
| Oct 2, 2026 | 14.34 | 14.34 | 14.01 | 14.08 | 265.20K |
| Oct 1, 2026 | 14.44 | 14.49 | 14.19 | 14.32 | 332.30K |
| Sep 30, 2026 | 14.82 | 14.89 | 14.65 | 14.65 | 198.80K |
| Sep 29, 2026 | 14.60 | 14.93 | 14.60 | 14.87 | 158.00K |
| Sep 28, 2026 | 14.48 | 14.62 | 14.31 | 14.50 | 241.70K |
| Sep 25, 2026 | 15.30 | 15.35 | 15.10 | 15.12 | 126.10K |
| Sep 24, 2026 | 15.15 | 15.59 | 15.15 | 15.48 | 236.80K |
| Sep 23, 2026 | 15.75 | 15.75 | 15.21 | 15.29 | 451.40K |
| Sep 22, 2026 | 15.51 | 16.03 | 15.46 | 15.92 | 198.50K |
| Sep 21, 2026 | 15.27 | 15.50 | 15.11 | 15.48 | 165.70K |
About Mesoblast
Mesoblast (MESO) is listed on the Nasdaq and classified by the SEC under “Biological Products, (No Diagnostic Substances)”. Its business address is in MELBOURNE, VICTORIA, Australia. State of incorporation: Australia. Fiscal year ends June 30. SEC CIK 1345099.
MESO board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Jane Catherine Bell | Director | Mar 18, 2026 |
| William Murray Burns | Director | Apr 1, 2026 |
| Lynette Elizabeth Cobley | Director | Apr 29, 2026 |
| Philip James Facchina | Director | Mar 18, 2026 |
| Gregory George | Director | Apr 13, 2026 |
| Silviu Itescu | CEO and Managing Director | Apr 1, 2026 |
| Philip R. Krause | Director | Mar 18, 2026 |
| Eric Allen Rose | Chief Medical Officer,Director | Mar 18, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Silviu Itescu | CEO and Managing Director | Apr 1, 2026 |
| James Michael Obrien | Chief Financial Officer | Jul 9, 2026 |
| Eric Allen Rose | Chief Medical Officer,Director | Mar 18, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Apr 10, 2026 | Gregory George | Buy | 2,324,072 | $1.48 |
| Apr 10, 2026 | Gregory George | Buy | 2,324,072 | $1.48 |
| Apr 10, 2026 | Gregory George | Buy | 2,324,072 | $1.48 |
| Apr 10, 2026 | Gregory George | Buy | 2,324,072 | $1.48 |
| Apr 10, 2026 | Gregory George | Buy | 2,324,072 | $1.48 |
| Apr 10, 2026 | Gregory George | Buy | 2,324,072 | $1.48 |
| Apr 10, 2026 | Gregory George | Buy | 2,324,072 | $1.48 |
| Apr 10, 2026 | Gregory George | Buy | 2,324,072 | $1.48 |
| Apr 9, 2026 | Gregory George | Buy | 10,000 | $1.43 |
| Apr 9, 2026 | Gregory George | Buy | 5,000 | $1.43 |
| Apr 9, 2026 | Gregory George | Buy | 10,000 | $1.43 |
| Apr 9, 2026 | Gregory George | Buy | 10,000 | $1.43 |
| Apr 9, 2026 | Gregory George | Buy | 10,000 | $1.41 |
| Apr 9, 2026 | Gregory George | Buy | 10,000 | $1.44 |
| Apr 9, 2026 | Gregory George | Buy | 500,000 | $1.44 |
MESO financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| No annual XBRL figures available (foreign filers often report on Form 20-F). | ||||
Latest balance sheet: total assets $—, total liabilities $—, cash $—.
MESO earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| No 8-K earnings releases in recent filings. | ||
Related stocks · Biological Products, (No Diagnostic Substances)
Moderna (MRNA)Amgen (AMGN)Gilead Sciences (GILD)Twist Bioscience (TWST)Revolution Medicines (RVMD)Argenx Se (ARGX)Kodiak Sciences (KOD)Greenland Mines (GRML)Halozyme Therapeutics (HALO)Biogen (BIIB)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on MESO
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.